- Home
- RMTI vs ICCM Comparison
RMTI vs ICCM Comparison
Compare RMTI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMTI | ICCM |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | United States | Israel |
| Employees | 300 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 43.4M |
| IPO Year | 2022 | 2013 |
Fundamental Metrics
Financial Performance| Metric | RMTI | ICCM |
|---|---|---|
| Price | $0.90 | $0.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | $2.50 |
| AVG Volume (30 Days) | ★ 240.5K | 175.5K |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $101,489,000.00 | N/A |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | $8.14 | $31.38 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.38 | N/A |
| 52 Week Low | $0.78 | $0.54 |
| 52 Week High | $2.10 | $1.53 |
Technical Indicators
Market Signals| Indicator | RMTI | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 61.90 |
| Support Level | $0.80 | $0.68 |
| Resistance Level | $1.02 | $0.74 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 44.44 | 79.21 |
Price Performance
Historical ComparisonAbout RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.